Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Kelsen

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1988
Phase I trial of concurrent intraperitoneal and continuous intravenous infusion of fluorouracil in patients with refractory cancerB Reichman, M Markman, T Hakes, et al.
Cancer|December 15, 1990
Interferon alpha-2a and 5-fluorouracil for advanced colorectal carcinoma. Assessment of activity and toxicityN Kemeny, A Younes, K Seiter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1992
Intrapleural cisplatin and mitomycin for malignant mesothelioma following pleurectomy: pharmacokinetic studiesV W Rusch, D Niedzwiecki, Y Tao, et al.
Cancer|January 15, 1994
Preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for rectal cancerB Minsky, A Cohen, W Enker, et al.
Cancer|November 1, 1996
A phase I trial of a modified, dose intensive FAMTX regimen (high dose 5-fluorouracil+doxorubicin+high dose methotrexate+leucovorin) with oral uridine rescueG K Schwartz, K Christman, L Saltz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2001
Phase II study of the cyclin-dependent kinase inhibitor flavopiridol administered to patients with advanced gastric carcinomaG K Schwartz, D Ilson, L Saltz, et al.
Cancer Research|March 15, 1988
Randomized trial of combined modality therapy with and without thymosin fraction V in the treatment of small cell lung cancerH I Scher, B Shank, R Chapman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1992
FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancerD Kelsen, O T Atiq, L Saltz, et al.
Cancer|November 15, 1994
A phase I trial of intrahepatic verapamil and doxorubicin. Regional therapy to overcome multidrug resistanceL Saltz, B Murphy, N Kemeny, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1995
Phase I radioimmunotherapy trial with iodine-131-CC49 in metastatic colon carcinomaC R Divgi, A M Scott, L Dantis, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1988
Phase I trial of concurrent intraperitoneal and continuous intravenous infusion of fluorouracil in patients with refractory cancerB Reichman, M Markman, T Hakes, et al.
Cancer|December 15, 1990
Interferon alpha-2a and 5-fluorouracil for advanced colorectal carcinoma. Assessment of activity and toxicityN Kemeny, A Younes, K Seiter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1992
Intrapleural cisplatin and mitomycin for malignant mesothelioma following pleurectomy: pharmacokinetic studiesV W Rusch, D Niedzwiecki, Y Tao, et al.
Cancer|January 15, 1994
Preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for rectal cancerB Minsky, A Cohen, W Enker, et al.
Cancer|November 1, 1996
A phase I trial of a modified, dose intensive FAMTX regimen (high dose 5-fluorouracil+doxorubicin+high dose methotrexate+leucovorin) with oral uridine rescueG K Schwartz, K Christman, L Saltz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2001
Phase II study of the cyclin-dependent kinase inhibitor flavopiridol administered to patients with advanced gastric carcinomaG K Schwartz, D Ilson, L Saltz, et al.
Cancer Research|March 15, 1988
Randomized trial of combined modality therapy with and without thymosin fraction V in the treatment of small cell lung cancerH I Scher, B Shank, R Chapman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1992
FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancerD Kelsen, O T Atiq, L Saltz, et al.
Cancer|November 15, 1994
A phase I trial of intrahepatic verapamil and doxorubicin. Regional therapy to overcome multidrug resistanceL Saltz, B Murphy, N Kemeny, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1995
Phase I radioimmunotherapy trial with iodine-131-CC49 in metastatic colon carcinomaC R Divgi, A M Scott, L Dantis, et al.
Pageof 8